Cleveland BioLabs, RPCI Publish Studies Defining Role of Liver in Activity of Entolimod
Wednesday, May 1, 2013 - 08:30
in Health & Medicine
Studies by Cleveland BioLabs and Roswell Park Cancer Institute identify the liver as a key mediator of the tissue-protective and anticancer activities of Entolimod, a TLR5 agonist; agent prevented some liver metastases in preclinical analysis.